Foundation Medicine Executive and Leadership Team

Archana Murali, the Director, Corporate Strategy & Chief Executive Officer, Office of at Foundation Medicine, directs long-term growth initiatives and enterprise-wide strategic planning. By analyzing molecular profiling market trends, Murali architects frameworks that align research capabilities with clinical care requirements. This leadership role involves coordinating cross-functional teams to ensure scientific excellence remains central to all corporate objectives. Archana Murali maintains oversight of the executive office, facilitating communication between senior leadership and external partners to accelerate precision medicine adoption. Through rigorous evaluation of business performance, the Director, Corporate Strategy & Chief Executive Officer, Office of identifies opportunities for expanding the reach of genomic testing services. These efforts support the broader mission of providing physicians with actionable data for cancer treatment decisions. Ultimately, the Director, Corporate Strategy & Chief Executive Officer, Office of secures the competitive position of the organization within the global oncology landscape.

Dominique Schutz, the Chief Financial Officer & Head of Corporate Management at Foundation Medicine, directs all fiscal planning, capital allocation, and corporate governance activities. By managing the financial health of the organization, Schutz ensures sufficient investment in molecular profiling technology and research infrastructure. This role involves overseeing budgetary discipline across all departments to maximize the impact of precision medicine initiatives. Dominique Schutz leads the financial reporting process, providing transparency to stakeholders regarding the company's market performance and growth trajectory. As the Chief Financial Officer & Head of Corporate Management, Schutz evaluates investment opportunities that align with the company's commitment to scientific excellence. These financial strategies enable the organization to expand its global footprint and enhance clinical care standards. Through rigorous fiscal oversight, the Chief Financial Officer & Head of Corporate Management secures the resources necessary for developing new medicines and supporting cancer researchers in their pursuit of actionable patient insights.

Rachel von Staats, the Director, Office of the Chief Operating Officer at Foundation Medicine, manages daily operational workflows and internal process optimization. Overseeing the execution of strategic projects, von Staats ensures that laboratory operations and data analysis services meet stringent quality standards. This role requires constant collaboration with department heads to streamline resource allocation across North American and international markets. Rachel von Staats monitors key performance indicators to drive efficiency in molecular profiling delivery, directly impacting the speed of clinical reporting. By refining operational protocols, the Director, Office of the Chief Operating Officer enables the organization to scale research capabilities effectively. The Director, Office of the Chief Operating Officer maintains alignment between operational output and the overarching goal of supporting cancer researchers. Through meticulous management of internal systems, von Staats fosters an environment where precision medicine solutions reach patients with maximum reliability and scientific integrity.

Beatriz Garcia-Madrid, the Executive Business Partner To the Chief Operating Officer at Foundation Medicine, coordinates high-level operational priorities and executive communications. By managing the complex schedule and strategic agenda of the Chief Operating Officer, Garcia-Madrid ensures that leadership focus remains on critical molecular profiling milestones. This role involves facilitating cross-departmental collaboration to resolve operational bottlenecks and improve service delivery speed. Beatriz Garcia-Madrid monitors the progress of key initiatives, providing the Chief Operating Officer with the data necessary for informed decision-making. As the Executive Business Partner To the Chief Operating Officer, Garcia-Madrid maintains strong relationships with internal stakeholders to foster a culture of accountability and scientific rigor. These efforts support the organization's ability to provide physicians with timely, accurate cancer biology insights. Through proactive management of executive workflows, the Executive Business Partner To the Chief Operating Officer enables the leadership team to drive precision cancer care forward across diverse global markets.

Kierstin Smolinski, the Senior Director, People Operations & Organizational Development Chief of Staff at Foundation Medicine, designs talent management strategies and organizational culture initiatives. By architecting professional development programs, Smolinski ensures the workforce possesses the specialized skills required for advanced molecular profiling. This leadership role involves integrating human capital planning with the broader corporate mission to maintain high levels of scientific expertise. Kierstin Smolinski oversees the implementation of performance management systems that reward innovation and collaborative research efforts. As the Senior Director, People Operations & Organizational Development Chief of Staff, Smolinski facilitates communication between the executive team and staff to ensure operational transparency. These efforts drive employee engagement and retention, which are critical for sustaining the company's leadership in precision cancer care. Through strategic workforce planning, the Senior Director, People Operations & Organizational Development Chief of Staff supports the long-term scalability of the organization's research and clinical service divisions.

Andrew Suchoff, the Chief People Officer at Foundation Medicine, leads the global human resources strategy, focusing on talent acquisition and organizational health. By cultivating a workforce dedicated to precision medicine, Suchoff ensures the company attracts top-tier scientists and clinical experts. This role involves designing compensation and benefits structures that reflect the high value of specialized cancer research roles. Andrew Suchoff oversees diversity and inclusion programs to foster an innovative environment where diverse perspectives drive scientific breakthroughs. As the Chief People Officer, Suchoff partners with the executive team to align organizational structure with the company's long-term research goals. These efforts support the mission of providing physicians with actionable data by ensuring the right talent is in place to execute complex molecular profiling tasks. Through strategic leadership of the people function, the Chief People Officer maintains the organizational stability required to set the standard for quality and excellence in the cancer community.

Lisa Brien, the Senior Administrative Partner at Foundation Medicine, manages complex administrative operations and executive support systems. By optimizing office workflows and communication channels, Brien ensures that leadership teams operate with maximum efficiency. This role involves coordinating high-stakes meetings and project timelines that support the company's molecular profiling research and clinical service delivery. Lisa Brien maintains oversight of administrative resources, ensuring that all departments have the necessary support to meet their scientific and regulatory objectives. As the Senior Administrative Partner, Brien facilitates seamless interaction between internal teams and external partners, contributing to the overall cohesion of the organization. These efforts allow the executive leadership to focus on strategic initiatives that shape the future of precision cancer care. Through meticulous attention to detail and process management, the Senior Administrative Partner supports the company's commitment to quality and scientific excellence in every aspect of the business.